. . . . . . . "[Reagents that target some of these gene products are currently in clinical trials; however, there are others such as immunotherapy against the mutated TP53 protein and human CG treatment of high risk breast cancer patients that warrant testing in this context.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:17:00+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .